Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Hepatic Steatosis in HIV
NCT00441272Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in hepatic steatosis, sponsored by National Institute of Allergy and Infectious Diseases. Started Feb 2007; status: completed.
02
Drugs
pioglitazone
03
Conditions
hepatic steatosis
Beyond the preview
Go deeper on NCT00441272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00441272.